Market Cap 613.02B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 23.73
Forward PE 21.17
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 16,316,700
Avg Vol 8,309,220
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 98%
Beta 0.26
Analysts Strong Sell
Price Target $259.88

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
ewforecast
ewforecast Jun. 29 at 2:26 PM
$JNJ Johnson & Johnson Flashback Update: Wave 5 Extension in Progress Toward New Highs #JohnsonAndJohnson #elliottwave #freechart Check it below👇 https://wavetraders.com/free-charts/johnson-johnson-flashback-update-wave-5-extension-in-progress-jun-29-2026/
0 · Reply
ZacksResearch
ZacksResearch Jun. 29 at 1:31 PM
"Biotech is on fire 🔥 But which names are driving the rally? $LLY, $ABBV, $JNJ and $BIIB all hit fresh 52-week highs as strong pipeline progress, regulatory wins, approvals and M&A activity fueled growing confidence across the biotech sector. 📈 Latest LLY news here👉 " https://www.zacks.com/stock/quote/LLY?cid=sm-stocktwits-0-quote_overview-oc-38568&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_38568
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 29 at 1:18 PM
$ELTP $WEN $GME $PFE $JNJ Earning after close....... Have a great day.......
0 · Reply
Kingjake26
Kingjake26 Jun. 29 at 1:03 PM
$CADL Seriously. Let this sink IN. LIFE CHANGING. $JNJ it’s going to cost you a ton. $MRK Phase 3 and Practice-Changing Requirements: The journal rarely accepts early-stage or speculative data. To get a major feature, the data typically must come from robust, randomized, placebo-controlled clinical trials (like Candel's Phase 3 trial) and must demonstrate findings that could directly alter how doctors treat cancer patients globally.
0 · Reply
KryptonResearch
KryptonResearch Jun. 29 at 12:37 PM
While markets are extremely focused on the inputs to the AI trade (and for good reason, as this is where the capital is flowing at the present moment). We take a look at the flip side of the AI trade. Those using AI to accelerate their businesses. Today’s investment is one of our favorites. A great business and revolutionary technology, but more importantly, one that is going to transform the lives of billions. $LLY $NVO $ABBV $PFE $JNJ Take a read: https://kryptonresearch.substack.com/p/blood-money
0 · Reply
cwEWF
cwEWF Jun. 29 at 11:27 AM
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jun. 29 at 9:05 AM
$JNJ favors rally towards 271.4 in daily It managed to break to new high in daily from #bluebox area as anticipated. Short term pullback in 3, 7 or 11 swings against 6.22.2026 low should remain supported to continue rally in ((5)). #Elliottwave #JNJ
0 · Reply
JoshAlphaOne
JoshAlphaOne Jun. 29 at 8:23 AM
🐢 $JNJ Swing Setup Johnson & Johnson just broke out of a multi-month base. Entry Zone: $248.19 – $254.66 Stop: Below $220.84 Target 1: $305.59 Target 2: $381.99 Healthcare rotation heating up + political tailwinds. Patience on the pullback. Trend is intact.
0 · Reply
howardlindzon
howardlindzon Jun. 29 at 2:13 AM
$XBI up 7 percxent since I added to my portfolio and shared now $XLV coming to the party after being a dog the last year it was the BEST EVER relaive week for healtcare relative to $SPY https://x.com/ThierryBorgeat/status/2071315993649934707 the narrative is key and i assume it will be - 'look how much these companies can save deploying ai to fast track research yada yada yada and a lot of this will be true. I chose index because I have no clue how to pick stocks in this sector wiuth conviction other than Eli Lily with the clear lead in fat pills/needles (I am a customer). so what happened last week $LLY all time high, $JNJ all time high and Merck near one. the degenerates will surely learn the tickers if the priuces keep going up as they did with NFT's and crypto and ai and space Im old and boring for now with the diversified index Genomics breaking out too
0 · Reply
RaddyRad
RaddyRad Jun. 29 at 12:44 AM
$SLS all day......$LLY $MRK $ABBV $JNJ
1 · Reply
Latest News on JNJ
Johnson & Johnson presents first results from ENERGY study

2026-06-11T09:26:54.000Z - 18 days ago

Johnson & Johnson presents first results from ENERGY study


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 21 days ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to acquire Firefly Bio for $1B in cash

2026-06-08T12:14:56.000Z - 21 days ago

Johnson & Johnson to acquire Firefly Bio for $1B in cash


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 21 days ago

Johnson & Johnson to buy Firefly Bio for $1 billion


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 5 weeks ago

Johnson & Johnson says nipocalimab approved in China


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 7 weeks ago

CVS to drop J&J's Stelara from its main formularies

CVS


J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine

May 2, 2026, 4:00 AM EDT - 2 months ago

J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 2 months ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 2 months ago

J&J sees AI halving the time to generate drug development leads


ewforecast
ewforecast Jun. 29 at 2:26 PM
$JNJ Johnson & Johnson Flashback Update: Wave 5 Extension in Progress Toward New Highs #JohnsonAndJohnson #elliottwave #freechart Check it below👇 https://wavetraders.com/free-charts/johnson-johnson-flashback-update-wave-5-extension-in-progress-jun-29-2026/
0 · Reply
ZacksResearch
ZacksResearch Jun. 29 at 1:31 PM
"Biotech is on fire 🔥 But which names are driving the rally? $LLY, $ABBV, $JNJ and $BIIB all hit fresh 52-week highs as strong pipeline progress, regulatory wins, approvals and M&A activity fueled growing confidence across the biotech sector. 📈 Latest LLY news here👉 " https://www.zacks.com/stock/quote/LLY?cid=sm-stocktwits-0-quote_overview-oc-38568&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_38568
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 29 at 1:18 PM
$ELTP $WEN $GME $PFE $JNJ Earning after close....... Have a great day.......
0 · Reply
Kingjake26
Kingjake26 Jun. 29 at 1:03 PM
$CADL Seriously. Let this sink IN. LIFE CHANGING. $JNJ it’s going to cost you a ton. $MRK Phase 3 and Practice-Changing Requirements: The journal rarely accepts early-stage or speculative data. To get a major feature, the data typically must come from robust, randomized, placebo-controlled clinical trials (like Candel's Phase 3 trial) and must demonstrate findings that could directly alter how doctors treat cancer patients globally.
0 · Reply
KryptonResearch
KryptonResearch Jun. 29 at 12:37 PM
While markets are extremely focused on the inputs to the AI trade (and for good reason, as this is where the capital is flowing at the present moment). We take a look at the flip side of the AI trade. Those using AI to accelerate their businesses. Today’s investment is one of our favorites. A great business and revolutionary technology, but more importantly, one that is going to transform the lives of billions. $LLY $NVO $ABBV $PFE $JNJ Take a read: https://kryptonresearch.substack.com/p/blood-money
0 · Reply
cwEWF
cwEWF Jun. 29 at 11:27 AM
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jun. 29 at 9:05 AM
$JNJ favors rally towards 271.4 in daily It managed to break to new high in daily from #bluebox area as anticipated. Short term pullback in 3, 7 or 11 swings against 6.22.2026 low should remain supported to continue rally in ((5)). #Elliottwave #JNJ
0 · Reply
JoshAlphaOne
JoshAlphaOne Jun. 29 at 8:23 AM
🐢 $JNJ Swing Setup Johnson & Johnson just broke out of a multi-month base. Entry Zone: $248.19 – $254.66 Stop: Below $220.84 Target 1: $305.59 Target 2: $381.99 Healthcare rotation heating up + political tailwinds. Patience on the pullback. Trend is intact.
0 · Reply
howardlindzon
howardlindzon Jun. 29 at 2:13 AM
$XBI up 7 percxent since I added to my portfolio and shared now $XLV coming to the party after being a dog the last year it was the BEST EVER relaive week for healtcare relative to $SPY https://x.com/ThierryBorgeat/status/2071315993649934707 the narrative is key and i assume it will be - 'look how much these companies can save deploying ai to fast track research yada yada yada and a lot of this will be true. I chose index because I have no clue how to pick stocks in this sector wiuth conviction other than Eli Lily with the clear lead in fat pills/needles (I am a customer). so what happened last week $LLY all time high, $JNJ all time high and Merck near one. the degenerates will surely learn the tickers if the priuces keep going up as they did with NFT's and crypto and ai and space Im old and boring for now with the diversified index Genomics breaking out too
0 · Reply
RaddyRad
RaddyRad Jun. 29 at 12:44 AM
$SLS all day......$LLY $MRK $ABBV $JNJ
1 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 28 at 9:11 PM
Healthcare is starting to wake up again. $LLY $MRK $UNH $JNJ We’re seeing multiple names transition from long bases into early breakout structures. $LLY clearing an 8-month consolidation on expanding volume $MRK building a massive multi-year base $UNH still holding a clean Stage 2 uptrend structure $JNJ pushing into new all-time highs with steady institutional demand When multiple leaders in one sector start moving together, it usually signals rotation-not isolated strength. This looks less like individual breakouts and more like a sector-wide expansion phase forming underneath the surface.
0 · Reply
vu_jade
vu_jade Jun. 28 at 4:44 PM
$VKTX Maybe it’s time for $JNJ to make a nice acquisition … #SKOL
2 · Reply
BioTechHealthX
BioTechHealthX Jun. 28 at 7:25 AM
$JNJ Johnson & Johnson (JNJ) may be one of the oldest names in healthcare, but its MedTech launches, innovative medicine portfolio, institutional backing, and AI-powered healthcare potential show why this blue-chip healthcare stock still deserves serious investor attention. https://biotechhealthx.com/biotech-news/is-johnson-johnson-jnj-still-one-of-the-safest-healthcare-stocks-to-buy/
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 28 at 6:11 AM
$REGN $JNJ $LLY $PFE $SYK Artificial intelligence is no longer just a tech story. These healthcare stocks are using AI, automation, digital platforms, and advanced medical tools to improve clinical workflows, diagnostics, drug development, and patient outcomes. https://biotechhealthx.com/biotech-news/top-5-ai-powered-healthcare-stocks-that-can-make-you-rich/
0 · Reply
chalz_joshua_
chalz_joshua_ Jun. 27 at 11:09 PM
$JNJ 🔥🔥📈
0 · Reply
Tetoooo
Tetoooo Jun. 27 at 10:55 PM
$JNJ I run triple AI models GPT, GIMINAI, and Claude to analyze this stock with http://TrioVate.ai it is free
0 · Reply
howardlindzon
howardlindzon Jun. 27 at 10:46 PM
$JNJ wow all time highs. bandaids
4 · Reply
CosmicMiner
CosmicMiner Jun. 27 at 10:37 PM
$JNJ has been incredibly strong, surging to $254.66 and hitting a new 52-week high! As a healthcare giant, its robust pharma pipeline and med-tech growth are drawing heavy defensive inflows. This rally looks solid.
1 · Reply
KryptonResearch
KryptonResearch Jun. 27 at 10:14 PM
While markets are extremely focused on the inputs to the AI trade (and for good reason, as this is where the capital is flowing at the present moment). We take a look at the flip side of the AI trade. Those using AI to accelerate their businesses. Today’s investment is one of our favorites. A great business and revolutionary technology, but more importantly, one that is going to transform the lives of billions. $LLY $NVO $ABBV $PFE $JNJ Take a read: https://kryptonresearch.substack.com/p/blood-money
1 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 27 at 10:03 PM
Rotation is doing exactly what it usually does late-cycle- money stops chasing momentum and starts hiding in defensives with visible cash flows. This week the tape flipped hard: $ABBV +17% | pharma leadership catching bid on defensive + yield rotation $MRK +13% | large-cap healthcare strength as risk appetite fades $JNJ +12% | classic safety trade back in favor $DHR +11% | life sciences tools seeing steady institutional demand $LLY +10% | still strong structurally, but now part of broader defensive bid Meanwhile semis are cooling as AI beta unwinds from stretched positioning. This isn’t “AI is dead” pricing. It’s capital rotating from narrative to stability. When healthcare leads and semis lag, the market is telling you one thing: risk is being reduced, not added
0 · Reply
CapitalLogic1
CapitalLogic1 Jun. 27 at 9:07 PM
$JNJ still trending in a slow, steady way. No real volatility here, just consistent grinding higher without much attention. Moves feel orderly, more like a defensive name just doing its thing while the rest of the market swings around.
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 27 at 2:10 PM
This week’s tape rotation is pretty clear - AI and semis took a breather, while defensives quietly led. 1-week returns: $ABBV +17% (AbbVie) $MRK +13% (Merck) $JNJ +12% (Johnson & Johnson) $DHR +11% (Danaher) $LLY +10% (Eli Lilly) What stands out isn’t just performance, but leadership shifting into healthcare while high-beta growth cooled off. This kind of rotation usually says more about positioning stress than any single macro headline - when crowded trades unwind, capital doesn’t disappear, it just moves.
0 · Reply